AR079170A1 - Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par - Google Patents
Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio parInfo
- Publication number
- AR079170A1 AR079170A1 ARP100104417A ARP100104417A AR079170A1 AR 079170 A1 AR079170 A1 AR 079170A1 AR P100104417 A ARP100104417 A AR P100104417A AR P100104417 A ARP100104417 A AR P100104417A AR 079170 A1 AR079170 A1 AR 079170A1
- Authority
- AR
- Argentina
- Prior art keywords
- imidazo
- prepare
- pharmaceutical composition
- treatment
- inhibitor
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000002131 composite material Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 229940123324 Acyltransferase inhibitor Drugs 0.000 abstract 1
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 abstract 1
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000002404 acyltransferase inhibitor Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- XKZRHJPCEMWNIX-UHFFFAOYSA-N imidazo[4,5-i][1]benzazepine Chemical compound C1=CC=CN=C2C3=NC=NC3=CC=C21 XKZRHJPCEMWNIX-UHFFFAOYSA-N 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28531709P | 2009-12-10 | 2009-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR079170A1 true AR079170A1 (es) | 2011-12-28 |
Family
ID=43569741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100104417A AR079170A1 (es) | 2009-12-10 | 2010-11-30 | Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8299061B2 (enExample) |
| EP (1) | EP2509981B1 (enExample) |
| JP (1) | JP5631411B2 (enExample) |
| KR (1) | KR101395428B1 (enExample) |
| CN (1) | CN102666543B (enExample) |
| AR (1) | AR079170A1 (enExample) |
| AU (1) | AU2010328410B2 (enExample) |
| BR (1) | BR112012013918A2 (enExample) |
| CA (1) | CA2783684C (enExample) |
| EA (1) | EA020128B1 (enExample) |
| ES (1) | ES2509922T3 (enExample) |
| MX (1) | MX2012006646A (enExample) |
| TW (1) | TWI392680B (enExample) |
| WO (1) | WO2011071840A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| US8841487B2 (en) | 2010-07-16 | 2014-09-23 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| NZ705225A (en) | 2010-07-16 | 2016-11-25 | Abbvie Bahamas Ltd | Process for preparing antiviral compounds |
| WO2015120610A1 (en) * | 2014-02-14 | 2015-08-20 | Eli Lilly And Company | Gpr142 agonist compound |
| CN105153195B (zh) * | 2015-09-01 | 2017-09-26 | 汤文建 | 一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途 |
| CA3142360C (en) * | 2019-05-31 | 2023-11-14 | Medshine Discovery Inc. | Bicyclic compound as rip-1 kinase inhibitor and application thereof |
| TWI824259B (zh) * | 2020-07-01 | 2023-12-01 | 美商雷傑製藥公司 | Rip1k抑制劑 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847248A (en) * | 1986-12-23 | 1989-07-11 | Merck & Co., Inc. | 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists |
| US4735941A (en) * | 1986-12-23 | 1988-04-05 | Merck & Co., Inc. | 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents |
| EP0272866A1 (en) | 1986-12-23 | 1988-06-29 | Merck & Co. Inc. | 1,4-Benzodiazepines with 5-membered heterocyclic rings |
| IL101850A (en) * | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them |
| EP0523846A3 (en) | 1991-06-14 | 1993-03-17 | Merck & Co. Inc. | 1,4-benzodiazepines with 5-membered heterocyclic rings |
| US5679672A (en) * | 1993-11-22 | 1997-10-21 | Merck & Co., Inc. | Benzodiazepines |
| DK0730581T3 (da) * | 1993-11-22 | 2001-11-26 | Merck & Co Inc | 3-acylaminobezazepiner |
| US5439906A (en) * | 1993-11-22 | 1995-08-08 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
| US5834464A (en) * | 1994-11-18 | 1998-11-10 | Merck & Co., Inc. | Imidazolinobenzodiazepines |
| ZA9711537B (en) | 1996-12-23 | 1998-06-25 | Athena Neurosciences Inc Eli L | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting ß-amyloid peptide release and/or its synthesis by use of such compounds. |
| GB0012671D0 (en) * | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
| EP1784390A2 (en) * | 2004-08-13 | 2007-05-16 | Amgen Inc. | Substituted benzofused heterocycles |
| JP2008540485A (ja) * | 2005-05-10 | 2008-11-20 | エフ．ホフマン−ラ ロシュ アーゲー | ジアシルグリセロールアシルトランスフェラーゼ阻害剤 |
| CA2615463A1 (en) | 2005-07-29 | 2007-02-08 | Merck & Co., Inc. | Heterocyclic benzodiazepine cgrp receptor antagonists |
| US7569590B2 (en) * | 2006-09-19 | 2009-08-04 | Bristol-Myers Squibb Company | Use of thianecarboxamides as dgat inhibitors |
| US8324241B2 (en) | 2008-04-11 | 2012-12-04 | Bristol-Myers Squibb Company | Triazolo compounds useful as DGAT1 inhibitors |
| WO2009126861A2 (en) | 2008-04-11 | 2009-10-15 | Bristol-Myers Squibb Company | Triazolopyridine compounds useful as dgat1 inhibitors |
| JP2010116364A (ja) * | 2008-11-14 | 2010-05-27 | Banyu Pharmaceut Co Ltd | アゼピノン誘導体 |
| US20110319396A1 (en) | 2009-01-23 | 2011-12-29 | Msd K.K. | Benzodiazepin-2-on derivatives |
| AU2010216632A1 (en) | 2009-02-17 | 2011-08-04 | Msd K.K. | 1,4-benzodiazepin-2-on derivatives |
-
2010
- 2010-11-30 AR ARP100104417A patent/AR079170A1/es not_active Application Discontinuation
- 2010-12-02 TW TW099141941A patent/TWI392680B/zh not_active IP Right Cessation
- 2010-12-07 US US12/961,714 patent/US8299061B2/en not_active Expired - Fee Related
- 2010-12-07 CN CN201080055334.9A patent/CN102666543B/zh not_active Expired - Fee Related
- 2010-12-07 CA CA2783684A patent/CA2783684C/en not_active Expired - Fee Related
- 2010-12-07 EP EP10799154.9A patent/EP2509981B1/en not_active Not-in-force
- 2010-12-07 KR KR1020127014795A patent/KR101395428B1/ko not_active Expired - Fee Related
- 2010-12-07 MX MX2012006646A patent/MX2012006646A/es unknown
- 2010-12-07 WO PCT/US2010/059158 patent/WO2011071840A1/en not_active Ceased
- 2010-12-07 BR BR112012013918A patent/BR112012013918A2/pt not_active IP Right Cessation
- 2010-12-07 EA EA201200868A patent/EA020128B1/ru not_active IP Right Cessation
- 2010-12-07 ES ES10799154.9T patent/ES2509922T3/es active Active
- 2010-12-07 AU AU2010328410A patent/AU2010328410B2/en not_active Ceased
- 2010-12-07 JP JP2012543187A patent/JP5631411B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010328410A1 (en) | 2012-07-26 |
| JP2013513607A (ja) | 2013-04-22 |
| EA020128B1 (ru) | 2014-08-29 |
| CN102666543A (zh) | 2012-09-12 |
| CN102666543B (zh) | 2014-12-24 |
| MX2012006646A (es) | 2012-06-25 |
| US20110144091A1 (en) | 2011-06-16 |
| KR101395428B1 (ko) | 2014-05-14 |
| CA2783684A1 (en) | 2011-06-16 |
| AU2010328410B2 (en) | 2014-02-06 |
| BR112012013918A2 (pt) | 2016-04-26 |
| TWI392680B (zh) | 2013-04-11 |
| TW201130844A (en) | 2011-09-16 |
| EP2509981A1 (en) | 2012-10-17 |
| EA201200868A1 (ru) | 2012-12-28 |
| WO2011071840A1 (en) | 2011-06-16 |
| ES2509922T3 (es) | 2014-10-20 |
| KR20120099457A (ko) | 2012-09-10 |
| US8299061B2 (en) | 2012-10-30 |
| EP2509981B1 (en) | 2014-08-06 |
| CA2783684C (en) | 2014-02-25 |
| JP5631411B2 (ja) | 2014-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR078522A1 (es) | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis | |
| AR064736A1 (es) | Agonistas de gpcr | |
| AR081819A1 (es) | Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades | |
| CL2010001368A1 (es) | Compuestos derivados de 1,3-tiazina; composicion farmaceutica que lo comprende; utiles para inhibir a la beta-secretasa | |
| UY32490A (es) | Inhibidores de beta-secretasa | |
| CO6640247A2 (es) | Compuesto[5.6]heterociclico o una sal farmacológicamente aceptable del mismo útil para la prevención de enfermedades asociadas con el metabolismo óseo | |
| AR065806A1 (es) | Derivados de quinolina, procesos para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de la artritis reumatoidea. | |
| AR068369A1 (es) | Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina" | |
| PE20141822A1 (es) | Inhibidor de la quinasa reguladora de la senal de apoptosis | |
| CL2012003546A1 (es) | Compuestos especifico acido 2-(3-(4-cianonaftalen-1-il)piridin-4-iltio)-2-metilprpanoico, en su uso fromula markush; composicion y combinacion farmaceutica que lo comprende; y uso del compuesto y de la combinacion farmaceutica en la preparacion de medicamentos para tratar enfermedades originadas por altos niveles de acido urico. | |
| EA201270216A1 (ru) | Фармацевтический состав | |
| MX2011013884A (es) | Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas. | |
| AR077277A1 (es) | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer | |
| PE20171255A1 (es) | Forma cristalina y amorfa de hemitartrato de genz 112638 como inhibidor de glucosilceramida sintasa | |
| ECSP13012755A (es) | Composiciones farmacéuticas que contienen un inhibidor de dgat1 | |
| CL2009000394A1 (es) | Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
| AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
| UY33241A (es) | ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?. | |
| BRPI0817096B8 (pt) | análogo de tiazolidinodiona e composição farmacêutica que o compreende | |
| BRPI1013821A8 (pt) | piridinas substituídas como antagonistas de ccr3. | |
| UY32062A (es) | Inhibidores de beta-secretasa | |
| UY31863A (es) | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar | |
| CO6351777A2 (es) | Compuestos de tetraciclina sustituidod con fluor en c7 | |
| CO6710904A2 (es) | Formulación farmaceútica para inhibir la hipermeabilidad vascular en un ánimal | |
| AR081870A1 (es) | Composicion farmaceutica que comprende un derivado de amida o sal farmaceuticamente aceptable del mismo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |